Kim van Rooij

Toward Personalized Sexual Medicine (Part 2): Testosterone Combined with a PDE5 Inhibitor Increases Sexual Satisfaction in Women with HSDD and FSAD, and a Low Sensitive System for Sexual Cues

Saskia Poels, Jos Bloemers, Kim van Rooij et al. · The Journal of Sexual Medicine · 2012 · 73 citations

Medicine, Endocrinology, Pharmacology +17

Toward Personalized Sexual Medicine (Part 3): Testosterone Combined with a Serotonin1A Receptor Agonist Increases Sexual Satisfaction in Women with HSDD and FSAD, and Dysfunctional Activation of Sexual Inhibitory Mechanisms

Kim van Rooij, Saskia Poels, Jos Bloemers et al. · The Journal of Sexual Medicine · 2012 · 64 citations

Medicine, Endocrinology, Pharmacology +17

Toward Personalized Sexual Medicine (Part 1): Integrating the “Dual Control Model” into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder

Jos Bloemers, Kim van Rooij, Saskia Poels et al. · The Journal of Sexual Medicine · 2012 · 62 citations

Medicine, Pharmacotherapy, Psychiatry +12

Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials

Adriaan Tuiten, Kim van Rooij, Jos Bloemers et al. · The Journal of Sexual Medicine · 2017 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women

Kim van Rooij, Jos Bloemers, Leo de Leede et al. · Psychoneuroendocrinology · 2011 · 31 citations

Medicine, Endocrinology, Pharmacokinetics +14